Eton Pharmaceuticals (ETON) Retained Earnings (2019 - 2025)
Historic Retained Earnings for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to -$114.0 million.
- Eton Pharmaceuticals' Retained Earnings fell 622.77% to -$114.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$114.0 million, marking a year-over-year decrease of 622.77%. This contributed to the annual value of -$107.9 million for FY2024, which is 367.35% down from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' Retained Earnings is -$114.0 million, which was down 622.77% from -$112.0 million recorded in Q2 2025.
- Eton Pharmaceuticals' 5-year Retained Earnings high stood at -$87.0 million for Q1 2021, and its period low was -$114.0 million during Q3 2025.
- In the last 5 years, Eton Pharmaceuticals' Retained Earnings had a median value of -$104.0 million in 2022 and averaged -$102.6 million.
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 1884.98% in 2021, then skyrocketed by 214.52% in 2023.
- Quarter analysis of 5 years shows Eton Pharmaceuticals' Retained Earnings stood at -$94.1 million in 2021, then fell by 9.59% to -$103.1 million in 2022, then dropped by 0.91% to -$104.1 million in 2023, then fell by 3.67% to -$107.9 million in 2024, then fell by 5.64% to -$114.0 million in 2025.
- Its Retained Earnings was -$114.0 million in Q3 2025, compared to -$112.0 million in Q2 2025 and -$109.5 million in Q1 2025.